Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating Polyneuropathy
These findings highlight the critical involvement of aberrant complement activation in the pathophysiology of CIDP and provide a rationale for further investigation into targeted complement inhibition as a therapeutic approach.
Authors
- Jan D. Lünemann (ORCID: https://orcid.org/0000-0002-3007-708X)
- Frauke Stascheit (ORCID: https://orcid.org/0000-0001-5306-7880)
- Andreas Meisel (ORCID: https://orcid.org/0000-0001-7233-5342)
- Katrin Hahn (ORCID: https://orcid.org/0000-0002-6013-0072)
- Helena F Pernice (ORCID: https://orcid.org/0009-0001-8711-5526)
- Kerstin Stein (ORCID: https://orcid.org/0009-0002-7202-0644)
- Hannah Preßler
Institutions
- German Center for Neurodegenerative Diseases (DE)
- Humboldt-Universität zu Berlin (DE)
- University Hospital Münster (DE)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1212/nxi.0000000000200542
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00